Recession-Proof System Revealed!

This strategy is largely traded by hedge funds, but has been kept a secret from retail traders for decades. While hedge funds focus on helping the super-rich, it's our mission to help the rest. Now you can use their secrets to grow your own trading account!

By clicking the link above you will automatically opt-in to receive emails from PriceActionEA

Officials investigate rare nervous system disorder in older adults who got RSV vaccine

MIKE STOBBE
February 29, 2024

NEW YORK (AP) -- Health officials are investigating whether there's a link between two new RSV vaccines and cases of a rare nervous system disorder in older U.S. adults.

The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said Thursday. And the available information is too limited to establish whether the shots caused the illnesses, they added.

But the numbers are higher than expected and officials are gathering more information to determine if the vaccines are causing the problem. The data was presented at a meeting of an expert panel that provides vaccine policy advice to the Centers for Disease Control and Prevention.

Officials said they were investigating more than 20 cases of Guillain-Barre syndrome, an rare illness in which a person's immune system damages nerve cells, causing muscle weakness and paralysis. An estimated 3,000 to 6,000 people develop GBS in the U.S. each year, and it's more commonly seen in older people, according to the CDC.

Most people fully recover from the syndrome, but some have permanent nerve damage. Guillain-Barre can occur in people after they are infected with a virus, but in some instances cases have been linked to vaccinations.

RSV, or respiratory syncytial virus, is a common cause of cold-like symptoms but it can be dangerous for infants and the elderly.

Last year, the CDC signed off on a recommendation made by the advisory panel, aimed at Americans age 60 and older. It was for a single dose of RSV vaccine. There were two options, one made by Pfizer and the other by GSK.

The CDC said that patients should talk to their doctors about the vaccines and then decide whether to get it.

Officials were aware that instances of Guillain-Barre had been identified in clinical trials done before the shots were approved for sale, and that different systems were watching for signs of problems.

At a meeting of the expert panel on Thursday, CDC officials presented an analysis of the reports taken in by those systems.

About two-thirds of the cases occurred in people who got a version of the vaccine made by Pfizer, called Abrysvo. But officials are also doing follow-up tracking in people who got Arexvy, made by GSK.

About two cases of Guillain-Barre might be seen in every 1 million people who receive a vaccine, health officials estimate. A CDC analysis found the the GSK rate was lower than that, but 4.6 cases per million were reported in recipients of the Pfizer shot.

Data from the U.S. Food and Drug Administration also showed an above-expected number of Guillain-Barre cases being reported in RSV vaccine recipients, with more among Pfizer shot recipients.

"Taken together, these data suggest a potential increased risk" in RSV vaccine recipients 60 and older that must be explored, said Dr. Tom Shimabukuro, a CDC vaccine safety monitoring official.

Officials from GSK and Pfizer made brief statements during the meeting, noting that sorting out a safety signal is complicated.

"Pfizer is committed to the continuous monitoring and evaluation of the safety of Abrysvo" and is conducting four safety studies to look into the possibility of vaccine-related GBS, said Reema Mehta, a Pfizer vice president.

CDC officials also presented estimates that the vaccines have prevented thousands of hospitalizations and hundreds of deaths from RSV, and that current data indicates the benefits of vaccination outweigh the possible risks.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group. The AP is solely responsible for all content.

Continue Reading...

Popular

Federal Judge Upholds Gun Case Against Hunter Biden, Rejects Political Motivation Claims

Federal judge denies dismissal of Hunter Biden's federal gun case, rejecting claims of political targeting; tax charges in LA also upheld.

How O.J. Simpson burned the Ford Bronco into America's collective memory

The Ford Bronco initially was conceived and designed for rugged outdoorsy types, a two-door means of escape to nature from the bustling cities of mid-century America.

Gold: Now Legal Tender - Ad

Most Americans missed this big story, but 1 in 5 states have now made gold and silver coins legal tender. It's just one reason why so many predict gold will soon hit $5,000. And why you need to check out this $5 strategy for gold immediately.

The EU plans to fast-track some financial aid to Egypt. The usual funding safeguards will not apply

BRUSSELS (AP) — The European Union intends to fast-track some of its aid money to Egypt using an urgent funding procedure that bypasses parliamentary oversight and other safeguards, according to the president of the bloc’s executive branch.

14.8 Trillion Shiba Inu Tokens Liquidated In Just 24 Hours Amid Market Downturn

Amid a bearish downturn affecting the crypto market on Friday, Shiba Inu (CRYPTO: SHIB) has experienced a significant liquidation event, with $3.63 million worth of SHIB, or approximately 14.8 trillion tokens,

Gold Is SOARING -- Here's What You Need to Do - Ad

Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in, for less than $5.

US Postal Service seeking to hike cost of first-class stamp to 73 cents

WASHINGTON (AP) — The U.S. Postal Service signaled plans Tuesday for a rate increase that includes hiking the cost of a first-class stamp from 68 cents to 73 cents, part of an overall 7.8% increase to take effect this summer.

Piedmont Advances NAL Operations; Royal Gold Subsidiary Sells 49,500 GEOs; Hecla Mining Reports Q1 Production And More: Tuesday's Top Mining Stories

Top stories for April 9, 2024: Piedmont Lithium and JV partner Sayona Mining aim for steady state production by 2024. Royal Gold sells 49,500 GEO in Q1. Hecla Mining sees increases in silver, gold, lead, and zinc production. Coeur Mining begins commercial production at expanded Rochester mine.

Buy This A.I. Stock Before Elon's "A.I. Day" on May 16 - Ad

Luke Lango is now recommending this little-known A.I. stock because it could supply Elon Musk with a critical piece of infrastructure for his new A.I. venture, something Luke is calling "Elon's A.I. 2.0". Once Elon reveals it on May 16, you may have missed the biggest gains.

Jim Cramer Turns Bullish On Palantir: 'Make A Move And Buy Some'

CNBC’s “Mad Money” host Jim Cramer has given a thumbs up to Palantir Technologies Inc. (NYSE:PLTR), sparking interest among investors.

In Blow To Trump, Court Agrees To Keep Witnesses Anonymous In Mar-a-Lago Documents Mishandling Case

In a recent development in the case against former U.S. President Donald Trump over alleged mishandling of classified documents, the court has ruled that the witnesses involved can remain anonymous.

The Man Who Bought Bitcoin at $5 Reveals His Next Tiny Crypto Gem for 2024 - Ad

Early Bitcoin Millionaire Charlie Shrem just revealed his five little-known crypto coins that he believes could create generational wealth over the next 12 months. What's more, some of these tiny cryptos he's discovered trade for less than $1!

What's Going On With Pratt & Whitney Parent RTX Shares Today?

RTX Corporation shares dip on Tuesday. Pratt & Whitney unveils North American Technology Accelerator, aiming to enhance MRO network development.

Culinary diplomacy: The internet is obsessed with what Janet Yellen eats in China

BEIJING (AP) — Ever since she ate mushrooms that can have psychedelic effects in Beijing last July, has united Americans and Chinese in wanting to know what she will eat next.

A.I. Pioneer Issues Urgent Warning to Americans - Ad

According to one early A.I. pioneer: "You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There's no middle option."

Top Crypto Analyst Says Bitcoin Could Retest All-Time High, 'If It Holds Above $69K'

Renowned crypto analyst Michaël van de Poppe has indicated that Bitcoin (CRYPTO: BTC) could be on the verge of testing its all-time high, contingent on its ability to maintain a key price level.

Ubisoft Accidentally Leaks Star Wars Outlaws Release Date, Special Editions And More

Uncover Ubisoft's leaked details on Star Wars Outlaws, including its release date, editions, bonuses, storyline and more!

The No. 1 AI Stock of 2024 (Not Nvidia) - Ad

It's not Nvidia, Meta Platforms, Alphabet, or Amazon. But thanks to a recent major deal, an under-the-radar stock could become the No. 1 winner of the AI boom. "This company just teamed up with one of the biggest power players in the AI industry... yet you can still buy it for just one-twelfth the price of Nvidia -- the time to buy is NOW," says Marc Chaikin.

Fundstrat's Tom Lee Encourages Investors to Seize Market Dip Amid Inflation Concerns, June Rate Cut Remains Feasible

In the wake of a market sell-off triggered by the inflation report, investors are being urged to buy stocks, with Fundstrat suggesting a potential June rate cut is still on the table.

The No. 1 Crypto for 2024 - Ad

We're entering the final crypto bull run, and 2024 will be your last chance to ever get rich from crypto. These five tiny cryptos are believed to create generational wealth over the next 12 months. $30 trillion is poised to funnel into the crypto markets thanks to a new government regulation just signed.

Top 2 Real Estate Stocks That Could Blast Off This Month

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

Make This One Trade Every Time the Government Drops Economic Reports - Ad

Twelve times every year... you have the chance to make ONE simple trade... with ONE symbol... And cash out the very next day! Some have gone up to 383% OVERNIGHT! It's a way to make winning trades every time the government releases key economic data.

Trump Has 'Taken Most Unfavorable Political Position' On Abortion, Says Ex-Bush Strategist

Former Bush strategist Matthew Dowd criticizes Trump's abortion stance, suggesting a 15-16 week policy would have been better. Trump's statement faces backlash and could hurt his chances in upcoming elections.

Why Gold Is Headed Above $3,000 - Ad

Many experts believe gold is headed to $3,000/oz. or even higher. As this rally picks up... most investors will likely run out and buy an ETF, a gold mining stock, or even bullion. But there's actually a much better way to profit from the emerging gold boom (with just $5.)

Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says

Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months.

Are AI Stocks in a Bubble? - Ad

Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. What does that mean if you're holding AI stocks? To get more information from a 50-year Wall Street veteran, Including the name and ticker symbol of his #1 stock to buy for what's ahead.

What's Going On With Charles Schwab Shares After Launching Forex Trading?

Charles Schwab introduces futures and forex trading on its thinkorswim platform suite, part of Schwab Trading Powered by Ameritrade.

Premier League to use semi-automated offside technology from next season

LONDON (AP) — The Premier League will use semi-automated offside technology from next season.

Billionaires Are Now FLOODING Into Gold - Ad

Ray Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5).

Top 3 Industrials Stocks That Are Set To Fly This Quarter

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.

Two tribal nations sue social media companies over Native youth suicides

Two tribal nations are accusing social media companies of contributing to the disproportionately high rates of suicide among Native American youth.

What Should You Be Doing To "A.I.-Proof" Your Retirement? - Ad

A.I. is creeping into every aspect of our daily lives... According to billion-dollar fund manager Louis Navellier, it's never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.

Time to Sell NVDA? 50-Yr Wall Street Legend Weighs In - Ad

If you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview before you move your money. There's a BETTER AI stock to buy than NVDA right now, especially in the coming $7 trillion A.I. boom.

Making cement is very damaging for the climate. One solution is opening in California

It's a major contributor to climate change — the way buildings and roads are made with concrete. It's also a problem that's growing as more of the world develops. So the race has been on to find solutions for a material that's responsible for roughly 8% of global carbon dioxide emissions.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service